{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:29:11Z","timestamp":1781292551993,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.transproceed.2016.05.017","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T04:31:43Z","timestamp":1480998703000},"page":"2924-2930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients"],"prefix":"10.1016","volume":"48","author":[{"given":"S.","family":"Brakemeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gaedeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.05.017_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/TP.0b013e3181aad256","article-title":"Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia","volume":"88","author":"Neff","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.05.017_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/523814","article-title":"Epidemiology and clinical significance of Pneumocystis colonization","volume":"197","author":"Morris","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/649868","article-title":"Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population","volume":"50","author":"Ponce","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2016.05.017_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajt.12947","article-title":"Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis","volume":"15","author":"Iriart","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s15010-014-0660-y","article-title":"Clindamycin-primaquine for Pneumocystis jiroveci pneumonia in renal transplant patients","volume":"42","author":"Nickel","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.transproceed.2016.05.017_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02111870","article-title":"Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit","volume":"14","author":"Hennequin","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.transproceed.2016.05.017_bib8","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1111\/j.1600-6143.2009.02914.x","article-title":"Pneumocystis pneumonia in solid organ transplant recipients","volume":"9","author":"Martin","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s15010-012-0277-y","article-title":"Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation","volume":"40","author":"Malhotra","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.transproceed.2016.05.017_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-6143.2009.02785.x","article-title":"Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients","volume":"10","author":"Kamar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib11","first-page":"673","article-title":"Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review","volume":"49","author":"de Boer","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.transproceed.2016.05.017_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1399-3062.2011.00645.x","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis","volume":"13","author":"de Boer","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/TP.0b013e3182384b57","article-title":"Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients","volume":"92","author":"Phipps","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.05.017_bib14","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/ndt\/gfr048","article-title":"Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation","volume":"26","author":"Struijk","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib15","doi-asserted-by":"crossref","first-page":"e0122171","DOI":"10.1371\/journal.pone.0122171","article-title":"Prophylaxis and treatment of Pneumocystis jiroveci pneumonia in lymphoma patients subjected to rituximab-contained therapy: a systemic review and meta-analysis","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2016.05.017_bib16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management","volume":"16","author":"Okumi","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/phar.1426","article-title":"Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options","volume":"34","author":"Kim","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2016.05.017_bib18","unstructured":"European Medicines Agency, European public assessment reports, product information: Belatacept (Nulojix\u00ae), last accessed 28-06-2016. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002098\/WC500108355.pdf."},{"key":"10.1016\/j.transproceed.2016.05.017_bib19","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.05.017_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ndt\/gfr278","article-title":"Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix) in renal transplant recipients","volume":"27","author":"Brakemeier","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.05.017_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2215\/CJN.05840710","article-title":"Switching from calcineurin inhibitor\u2013based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study","volume":"6","author":"Rostaing","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.05.017_bib24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff Meeting Report Writing Committee. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201909 meeting report: antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1600-6143.2009.02580.x","article-title":"Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study","volume":"9","author":"Canaud","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-3062.2011.00691.x","article-title":"Pneumocystis jirovecii pneumonia in kidney transplantation","volume":"13","author":"Goto","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/515126","article-title":"Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?","volume":"28","author":"Gordon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1399-3062.2003.00018.x","article-title":"Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case\u2013control study","volume":"5","author":"Radisic","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1399-3062.2011.00692.x","article-title":"Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis","volume":"13","author":"Anand","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib34","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.transproceed.2013.02.107","article-title":"Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience","volume":"45","author":"Borstnar","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.05.017_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-3062.2012.00740.x","article-title":"Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past","volume":"14","author":"Wang","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib36","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.transproceed.2012.09.089","article-title":"An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia","volume":"44","author":"Brunot","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.05.017_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfv388","article-title":"One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience","volume":"31","author":"Zschiedrich","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2016.05.017_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/tri.12234","article-title":"Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation","volume":"27","author":"Barnett","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2016.05.017_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-3062.2009.00366.x","article-title":"Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept","volume":"11","author":"Haidinger","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2016.05.017_bib40","first-page":"1491","article-title":"CD4 T-lymphocyte counts as predictors of pneumonia after kidney transplantation","volume":"25","author":"Bourbigot","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.05.017_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1469-0691.2010.03143.x","article-title":"Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after prophylaxis discontinuation: a case-control study","volume":"16","author":"de Castro","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.transproceed.2016.05.017_bib42","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/ndt\/gfq689","article-title":"Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients","volume":"26","author":"Eitner","year":"2011","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516305449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516305449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T05:50:54Z","timestamp":1536213054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516305449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0041134516305449"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.05.017","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}